ZAMBIA Medicines and Medical Supplies Agency Senior Manager Public Relations Bradley Chingobe says none of the Erythromycin which is currently on the market is defective and is safe to use. And Chingobe says Missionpharma has requested that the defective Erythromicin be tested by an independent lab because they contend that there’s nothing wrong with it. Last week, Health Minister Sylva Masebo told Parliament that ZAMMSA procured defective Erythromycin drugs which were delivered in the last consignment. In a follow up interview, Sunday, Chingobe said the defective Erythromycin was removed from the health kits which were not compliant while the one that was in the complaint health kits was distributed because there was nothing wrong with it. He said he was...

To continue reading this premium content, login to your account or Subscribe to our ePaper using the buttons below.
Log In Subscribe